Results, filtered by:
152 {0} - {1} of {2} items
GSK UK Products
This site provides information on GSK medicines and vaccines for members of the UK public, patients and their carers.
Mivacron
Mivacron (mivacurium chloride) links to the summary of product characteristics and patient information leaflet to support UK patients and carers when prescribed.
Ambirix product overview
Ambirix product information to support UK patients and carers when prescribed.
Contact us
GSK UK contact us page for members of the UK public
Products | GSK public UK
GSK product information for UK members of the public and patients
Report suspected side effect
Form for UK members of the public and patients that have been prescribed a GSK medicine or vaccine to report a suspected side effect
Haleraid | GSK public
Haleraid is a device developed to help patients with impaired hand agility administer a range of GSK inhalers.
Engerix B
Information on Engerix B vaccine for members of public including summary of product characteristics and patient information leaflet
Ambirix
Information on Ambirix vaccine for members of public including summary of product characteristics and patient information leaflet
Menveo
Information on Menveo vaccine for members of public including summary of product characteristics and patient information leaflet
Twinrix
Information on Twinrix vaccine for members of public including summary of product characteristics and patient information leaflet
Engerix B Paediatrics
Information on Engerix B Paediatrics vaccine for members of public including summary of product characteristics and patient information leaflet
Havrix Junior Monodose
Information on Havrix Junior Monodose vaccine for members of public including summary of product characteristics and patient information leaflet
Twinrix Paediatrics
Information on Twinrix Paediatrics vaccine for members of public including summary of product characteristics and patient information leaflet
Havrix Monodose
Information on Havrix Monodose vaccine for members of public including summary of product characteristics and patient information leaflet
Fendrix
Information on Fendrix vaccine for members of public including summary of product characteristics and patient information leaflet
XEVUDY▼ (sotrovimab) | For GB Public
Information on XEVUDY▼ (sotrovimab) for members of GB public including summary of product characteristics and patient information leaflet.
Omjjara ▼ (momelotinib) | GSK public UK
Omjjara ▼ (momelotinib) | Information for members of the public
AREXVY ▼
AREXVY patient information for members of the UK public
Bexsero
Information on Bexsero vaccine for members of public including summary of product characteristics and patient information leaflet.
Infanrix-IPV+Hib (Diptheria, tetanus, pertussis (acellular), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine adsorbed)) | GSK Public UK
Information on Infanrix-IPV+Hib (Diptheria, tetanus, pertussis (acellular), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine adsorbed)) for members of public including summary of product characteristics and patient information leaflet
Varilrix (live attenuated varicella-zoster (Oka strain) virus) | GSK Public UK
Information on Varilrix (live attenuated varicella-zoster (Oka strain) virus) for members of public including summary of product characteristics and patient information leaflet
Menitorix (hib, meningococcal group c combined vaccine) | GSK Public UK
Information on Menitorix (hib, meningococcal group c combined vaccine) for members of public including summary of product characteristics and patient information leaflet
MOP | SHINGRIX landing page
SHINGRIX patient information for members of the UK public
Bexsero overview
Information on Bexsero vaccine for members of public including summary of product characteristics and patient information leaflet.
Boostrix-IPV (diphtheria, tetanus, pertussis (acellular) and poliomyelitis (inactivated)) | GSK Public UK
Information on Boostrix-IPV (diphtheria, tetanus, pertussis (acellular) and poliomyelitis (inactivated)) for members of public including summary of product characteristics and patient information leaflet
Relenza (zanamivir) | GSK Public UK
Information on Relenza (zanamivir) for members of public including summary of product characteristics and patient information leaflet
Dectova ▼ (zanamivir hydrate) | GSK Public UK
Information on Dectova▼(zanamivir hydrate) for members of public including summary of product characteristics and patient information leaflet
Priorix (Measles, Mumps and Rubella vaccine (live)) | GSK Public UK
Information on Priorix (Measles, Mumps and Rubella vaccine (live)) for members of public including summary of product characteristics and patient information leaflet
Rotarix (live attenuated rotavirus vaccine) | GSK Public UK
Information on Rotarix (live attenuated rotavirus vaccine) for members of public including summary of product characteristics and patient information leaflet
Ellipta – About the Ellipta device | GSK Pharma UK | Public site
A product overview of the Ellipta device for members of the public or for patients prescribed an Ellipta medicine in the UK.
Zejula (niraparib) | I am a patient
Zejula (niraparib) patient support materials to help guide advanced ovarian cancer patients.
▼ JEMPERLI (dostarlimab) | GSK public UK
▼JEMPERLI (dostarlimab) information for UK members of the public.
Zejula (niraparib)
Information for members of public on Zejula (niraparib)
Ventolin (salbutamol) | GSK public UK
Ventolin (salbutamol) support for members of the public.
I am a patient
Information about how to use the Ellipta device for UK patients who have been prescribed a medicine to be taken via Ellipta.
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) product information for the UK members of the public
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) – Possible side effects
Information for patients who have been prescribed Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) in the UK. Information about the possible side effects.
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) – FAQs
Information for patients who have been prescribed Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) in the UK. Frequently asked questions.
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) – I am a patient
Information for patients who have been prescribed Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) in the UK. Including how to use the device and side effects.
TrelegyEllipta (fluticasone furoate/umeclidinium/vilanterol) – COPD Information
Information for patients who have been prescribed TrelegyEllipta (fluticasone furoate/umeclidinium/vilanterol) in the UK. Links to professional organisations, charities and other useful websites for COPD.
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) – My Medicine
Information for patients who have been prescribed Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) in the UK.
Show more
▼ - This medicine is subject to additional monitoring. This will allow quick identification of new safety information.
If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the Patient information leaflet.
You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store.
By reporting side effects you can help provide more information on the safety of this medicine.
